Advertisement
Advertisement
U.S. markets open in 7 hours 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Nascent Biotech, Inc. (NBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4210-0.0026 (-0.63%)
At close: 03:51PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4236
Open0.4081
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4081 - 0.4300
52 Week Range0.0400 - 0.4515
Volume20,850
Avg. Volume232,384
Market Cap49.285M
Beta (5Y Monthly)-3.60
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NBIO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NASCENT BIOTECH INC
    ANIP: Lowering target price to $36.00ANI PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement